Ng, Sze May 
ORCID: 0000-0002-3449-0541, Dearman, Sarah, Fisher, Mark, Mushtaq, Talat and Randell, Tabitha
(2023)
Paediatric Society and Hyperinsulinism Charity National Surveys on CGM Access for Patients With Recurrent Hypoglycaemia.
JOURNAL OF THE ENDOCRINE SOCIETY, 7 (4).
bvad021-.
|
PDF
Paediatric Society and Hyperinsulinism Charity National Surveys on CGM Access for Patients With Recurrent Hypoglycaemia.pdf - Open Access published version Download (240kB) | Preview |
Abstract
<h4>Context</h4>Recurrent hypoglycemia can result in significant neurological impairments in children and continuous glucose monitoring (CGM) technology has been shown to reduce recurrent hypoglycemia in conditions such as type 1 diabetes. In the United Kingdom, CGM devices are currently only recommended by the National Institute of Clinical Excellence (NICE) for patients with diabetes and not for other diagnoses.<h4>Objective</h4>To examine access to CGM technology for children and young people with recurrent hypoglycemia in the United Kingdom.<h4>Methods</h4>In 2021, the British Society of Paediatric Endocrinology and Diabetes (BSPED) conducted a national health professional survey in England, Wales, Scotland, and Northern Ireland looking at CGM access to funding for children and young people with recurrent hypoglycemia, without the diagnosis of diabetes. The UK Children's Hyperinsulinism Charity (UK CHC) also conducted a national patient survey.<h4>Results</h4>Responses from BSPED were received from 55 units while the UK CHC received 69 responses from individual families, the largest response to a survey carried out by the charity. The results of the BSPED and UK CHC surveys found that funding streams for CGM were highly variable. Only 29% were able to access CGM for recurrent hypoglycemia and from these, 65% were self-funding CGM. Quality of life benefits were evident from the UK CHC survey on the utility of CGM in reducing worry, improving sleep, lessening the burden of frequently finger-pricking and reducing out-of-hours appointments as a result of hypoglycemia. Patient-reported utilization rates of blood glucose test strips per week were significantly reduced.<h4>Conclusion</h4>BSPED and UK CHC national surveys support a call and a consideration for CGM access to be widened to patients who suffer from recurrent hypoglycemia such as those with hyperinsulinism or metabolic conditions. The prevention of recurrent hypoglycemia and improving quality of life for patients and carers remain a cornerstone management for people who suffer from frequent hypoglycemia. CGM education is critical to support its use and understand its limitations. Further research is warranted to determine the safety and efficacy of CGM in detection and reduction of hypoglycemic events, impact of hospital stay, and long-term neurological outcomes in those who suffer from recurrent hypoglceamia.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | continuous glucose monitoring, CGM, pediatric, hypoglycemia, hyperinsulinism |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 17 May 2023 13:41 |
| Last Modified: | 17 May 2023 13:41 |
| DOI: | 10.1210/jendso/bvad021 |
| Open Access URL: | https://doi.org/10.1210/jendso/bvad021 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3170437 |
Dimensions
Dimensions
